Hims & Hers CFO awarded 300,978 RSUs

Okupe Oluyemi reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Okupe Oluyemi reported acquisition or exercise transactions in this Form 4 filing.

Hims & Hers Health, Inc. reported that Chief Financial Officer Oluyemi Okupe received a grant of 300,978 Restricted Stock Units (RSUs), each representing a contingent right to one share of Class A common stock.

The RSUs are subject to a service-based vesting schedule over four years. They vest in substantially equal quarterly installments on March 15, June 15, September 15 and December 15, with the first vesting date on June 15, 2026, as long as the service condition is met.

Insider Trade Summary

Grant/Award: 300,978 shares

Grant/Award 1 txn

Insider Okupe Oluyemi

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit	300,978	$0.00	$0.00

Holdings After Transaction: Restricted Stock Unit — 300,978 contracts (Direct)

Footnotes (2)

1. F1. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.
2. F2. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Hims & Hers (HIMS) report for CFO Oluyemi Okupe?

Hims & Hers reported that CFO Oluyemi Okupe received a grant of 300,978 Restricted Stock Units. Each RSU represents a contingent right to one share of Class A common stock, reflecting a compensation-based equity award rather than an open-market stock purchase or sale.

How many RSUs were granted to the Hims & Hers (HIMS) CFO in this Form 4?

The CFO was granted 300,978 Restricted Stock Units. These RSUs convert into an equal number of Class A common shares upon vesting, tying a substantial portion of the executive’s potential compensation to the company’s long-term performance and continued service.

What is the vesting schedule for the 300,978 RSUs granted at Hims & Hers (HIMS)?

The 300,978 RSUs vest over four years in substantially equal quarterly installments. Vesting occurs on March 15, June 15, September 15 and December 15, with the first vesting date on June 15, 2026, subject to satisfying the service-based vesting requirement.

Does the Hims & Hers (HIMS) CFO’s RSU grant involve any immediate cash transaction?

The RSU grant does not involve an immediate cash transaction; the Form 4 shows a price of $0.00 per unit. Instead, the award provides a contingent right to receive Class A common shares as the service-based vesting conditions are met over time.

Are the RSUs granted to the Hims & Hers (HIMS) CFO tied to Class A common stock?

Yes, each Restricted Stock Unit granted to the CFO corresponds to one share of Class A common stock. This structure directly links the executive’s equity compensation to the company’s share value once the RSUs vest according to the specified quarterly schedule.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/13/2026 - 04:20 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Okupe Oluyemi

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CA 94123

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	03/11/2026		A		300,978		(2)	(2)	Class A Common Stock	300,978	$0	300,978	D

Explanation of Responses:

1. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

2. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2026.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Oluyemi Okupe	03/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.